<DOC>
	<DOCNO>NCT03050164</DOCNO>
	<brief_summary>The study design Open-Label，Randomized , Single-Dose , 2-way Crossover Bioequivalence Study . During session , subject administer single dose 250mg Gefitinib Tablet ( one Gefitinib Tablet 250mg Hunan Kelun one Iressa® Tablet 250mg AstraZeneca ) fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Gefitinib Tablets Under Fasting Conditions</brief_title>
	<detailed_description>An Open-Label，Randomized , Single-Dose , 2-way Crossover Bioequivalence Study . During session , subject randomly assign 1:1 ratio receive single 250-mg dose either test formulation ( Hunam Kelun ) reference formulation ( Iressa® Astrazeneca ) , vice versa , 21-day washout period administration period .</detailed_description>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>1 . Healthy male subject . 2 . At least 18 year age . 3 . Weight least 50kg body mass index 19 26 kg/m2 . 4 . Informed consent voluntary sign write informed consent . 5 . Can communicate researcher complete study accordance provision research . 1 . Abnormal diagnostic finding , clinical significance determine researcher ( physical examination , vital sign , ECG , Xray , blood routine examination , urine routine examination , blood biochemical examination coagulation test ) . 2 . Having functional gastrointestinal disease inadequate secretion gastric acid treat acid suppression . Which include gastro upset , dyspepsia , gastritis , gastric ulcer , duodenal ulcer , gastric secrete melanoma , etc . 3 . Taking drug alter environment gastrointestinal，especially alter gastrointestinal pH，within 30 day first dose . Such Proton pump inhibitors：thiophene , omeprazole , lansoprazole , esomeprazole , etc . H2 antagonist ranitidine：cimetidine , famotidine , etc .and antacid hydrogen carbonate Sodium , magnesium oxide , aluminum hydroxide , magnesium trisilicate , etc .and gastric mucosal protective agent：sucralfate，and . 4 . Not comply unified diet swallow difficulty . 5 . Allergic ingredient excipients study drug . 6 . History gastrointestinal disorder severe liver kidney disease ，which affect absorption metabolism drug far . 7 . History ocular surface damaging disease ( corneal perforation , ulcer , etc. ) . 8 . History serious blood disease . 9 . With skin , cardiovascular , liver , kidney , digestive , neurological , psychiatric , metabolic disorder , disease interfere result trial . 10 . History longterm excessive drinking ( 8 cup day , 1 cup = 250 mL ) tea , coffee caffeinated beverages，or 48 hour first dose intake food drink contain caffeine ( coffee , tea , chocolate , etc. ) . 11 . Ingested drink food rich xanthine grapefruit affect drug absorption , distribution , metabolism excretion . 12 . A positive result breath alcohol test previous alcohol abuse ( ie , men drink 28 standard unit week [ 1 standard unit define contain 14 gram alcohol , would find standard shot hard liquor , 12ounce bottle beer , 5ounce glass wine ] Or regular drinking ( 14 standard unit alcohol per week ) within 6 month trial . 13 . Daily intake 3 cigarette 3 month study 48 hour first dose intake tobacco type tobacco product within 48 hour first dose . 14 . Taking drug interact gefitinib （such CYP3A4 inhibitors： itraconazole , ketoconazole , clotrimazole , Ritonavir , etc .and CYP3A4/5 inducers：rifampicin , carbamazepine , phenobarbital , phenytoin , dexamethasone , etc .and CYP2D6 inhibitors：Fluoxetine , paroxetine , etc .） within 30 day first dose . And use prescription drug , nonprescription drug , Chinese herbal medicine , health product within 14 day first dose . 15 . Volunteer clinical drug study take clinical trial drug within 3 month prior study . 16 . Blood donation lose 450mL blood within 3 month prior study，or plan donate blood blood component within study period within 3 month end study . 17 . Suffering serious illness undergone major surgical procedure within 1 year firs dose . 18 . Abnormal blood coagulation , know tendency severe bleeding . 19 . A positive result drug test exist drug abuse ( eg , morphine , marijuana , methamphetamine , dimethylene bisoxamine amphetamine , ketamine , etc . ) within 1 year prior trial . 20 . A positive result hepatitis B surface antigen ( HBsAg ) , antihepatitis C virus ( HCV ) antibody , syphilis test , human immunodeficiency virus ( HIV ) test . 21 . Having fertility planning reluctant take appropriate contraceptive study within 6 month study . 22 . Other unfavorable factor diagnose investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>